This company has been marked as potentially delisted and may not be actively trading. NYSE:PAH Platform Specialty Products (PAH) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsTrendsBuy This Stock About Platform Specialty Products Stock (NYSE:PAH) 30 days 90 days 365 days Advanced Chart Get PAH alerts:Sign Up Key Stats Today's Range$19.12▼$20.2950-Day Range$9.46▼$11.2752-Week Range$9.09▼$13.54Volume4.91 million shsAverage Volume2.45 million shsMarket Capitalization$5.54 billionP/E Ratio25.29Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewElement Solutions, Inc. engages in the formulation of chemical solutions that enhance the performance of products people use every day. It operates through the following segments: Electronics and Industrial & Specialty. The Electronics segment focuses on the research and formulation of specialty chemicals and materials for all types of electronics hardware, from complex printed circuit board designs to new interconnection materials. The Industrial & Specialty segment comprises industrial solutions, graphic solutions, and energy solutions. The company was founded by Sir Martin E. Franklin on April 23, 2013 and is headquartered in Fort Lauderdale, FL.Read More… Receive PAH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Platform Specialty Products and its competitors with MarketBeat's FREE daily newsletter. Email Address PAH Stock News HeadlinesBioPharma Services Announces Expansion into Late-Stage Patient Trials and Integration with HEALWELL’s Artificial Intelligence Platform Capabilities to Become a Full-Service ...September 19, 2024 | msn.comMannKind (MNKD) Q1 2024 Earnings Call TranscriptMay 9, 2024 | msn.comTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.April 24, 2025 | Crypto 101 Media (Ad)United Therapeutics Corporation (NASDAQ:UTHR) Q1 2024 Earnings Call TranscriptMay 2, 2024 | msn.comQ1 2024 United Therapeutics Corp Earnings CallMay 2, 2024 | finance.yahoo.comPlatform Specialty Products earnings preview: what to expectApril 28, 2024 | markets.businessinsider.comPlatform versus Platformization: How CrowdStrike is winning the platform battleApril 20, 2024 | venturebeat.comFDA approves new drug that may help stop a rare, fatal condition that doctors call a ‘ticking time bomb’March 29, 2024 | uk.finance.yahoo.comSee More Headlines PAH Stock Analysis - Frequently Asked Questions How were Platform Specialty Products' earnings last quarter? Platform Specialty Products Co. (NYSE:PAH) released its quarterly earnings results on Thursday, August, 2nd. The specialty chemicals company reported $0.26 earnings per share for the quarter, topping analysts' consensus estimates of $0.24 by $0.02. The business's quarterly revenue was up 6.5% compared to the same quarter last year. What other stocks do shareholders of Platform Specialty Products own? Based on aggregate information from My MarketBeat watchlists, some other companies that Platform Specialty Products investors own include Two Harbors Investment (TWO), Meta Platforms (META), Micron Technology (MU), Alibaba Group (BABA), Deere & Company (DE), Gilead Sciences (GILD) and Tesla (TSLA). Company Calendar Last Earnings8/02/2018Today4/24/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorBasic Materials Industry Miscellaneous Chemical Products Sub-IndustryN/A Current SymbolNYSE:PAH CIK1590714 Webwww.platformspecialtyproducts.com Phone(561) 207-9600FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.76 Trailing P/E Ratio25.29 Forward P/E Ratio174.73 P/E Growth4.42Net Income$-296,200,000.00 Net Margins-14.14% Pretax MarginN/A Return on Equity8.48% Return on Assets2.23% Debt Debt-to-Equity Ratio2.55 Current Ratio2.19 Quick Ratio2.00 Sales & Book Value Annual Sales$3.78 billion Price / Sales1.47 Cash Flow$4.42 per share Price / Cash Flow4.35 Book Value$9.96 per share Price / Book1.93Miscellaneous Outstanding Shares288,330,000Free FloatN/AMarket Cap$5.54 billion OptionableNot Optionable Beta2.59 7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free Report This page (NYSE:PAH) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredTrump’s treachery Intuitive Surgical at $1.99. Nvidia at $11. Shorting Fannie Mae months before collapse. That’s this analyst’s ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Platform Specialty Products Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Platform Specialty Products With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.